Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Two compounds target drug-resistant brain cancer cells in laboratory tests

Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths. The current standard of care involves the use of temozolomide (TMZ), a chemotherapy medication. However, the tumor can be difficult to control because cancer cells evolve to…

Two compounds target drug-resistant brain cancer cells in laboratory tests

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Friday 6 November →